Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2025)
Elanco Animal Health (ELAN) has disclosed Cash from Investing Activities for 9 consecutive years, with -$64.0 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities rose 28.89% to -$64.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$279.0 million through Dec 2025, down 124.09% year-over-year, with the annual reading at -$279.0 million for FY2025, 124.09% down from the prior year.
- Cash from Investing Activities hit -$64.0 million in Q4 2025 for Elanco Animal Health, up from -$101.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.2 billion in Q3 2024 to a low of -$441.0 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged $50000.0 across 5 years, with a median of -$40.0 million in 2022.
- Biggest five-year swings in Cash from Investing Activities: tumbled 390.0% in 2022 and later surged 3555.56% in 2024.
- Year by year, Cash from Investing Activities stood at -$74.0 million in 2021, then dropped by 2.7% to -$76.0 million in 2022, then soared by 53.95% to -$35.0 million in 2023, then crashed by 157.14% to -$90.0 million in 2024, then increased by 28.89% to -$64.0 million in 2025.
- Business Quant data shows Cash from Investing Activities for ELAN at -$64.0 million in Q4 2025, -$101.0 million in Q3 2025, and -$56.0 million in Q2 2025.